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Activation of the MHC Class II Transactivator
CIITA by Interferon-g Requires Cooperative
Interaction between Stat1 and USF-1
the X box of MHC-II promoters (Reith et al., 1988), and
are present in an ubiquitous manner.
CIITA is the general regulator of MHC-II gene expres-
sion, both constitutive and inducible (Steimle et al.,
1993, 1994), and it is likely to function as a transcriptional
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coactivator interacting with the transcription factors1, rue Michel-Servet
bound to MHC-II promoters (Zhou and Glimcher, 1995).CH-1211 Geneva 4
CIITA expression pattern correlates with that of MHC-IISwitzerland
genes with a constitutive expression in MHC-II±positive
cells and tissues (Steimle et al., 1993, 1994). CIITA is
the obligatory mediator of IFNg-inducible MHC-II ex-Summary
pression (Steimle et al., 1994). Moreover, in plasmocytes
the extinction of MHC-II expression corresponds to CIITACIITA is the mediator of MHC class II gene induction by
repression (Silacci et al., 1994). CIITA and MHC-II geneinterferon-g (IFNg). The CIITA gene is itself selectively
expression are not only qualitatively but also quantita-activated via one of its four promoters (PIV). We show
tively correlated (Otten et al., 1998). Therefore, the regu-
here that three cis-acting elements, the GAS, the E
lation of MHC-II gene expression, constitutive as well
box, and the IRF-1±binding site, as well as the trans- as inducible, and its tissue specificity are entirely depen-
acting factors Stat1 and IRF-1, are essential for activa- dent on the control of CIITA gene expression itself.
tion of CIITA promoter IV by IFNg. Stat1 binds to the The CIITA gene is controlled by multiple promoters,
GAS site only in the presence of the ubiquitous factor leading to multiple CIITA transcripts with different first
USF-1, which binds to the adjacent E box. Indeed, exons (Muhlethaler-Mottet et al., 1997). More importantly,
Stat1 and USF-1 bind to the GAS/E box motif in a these promoters are activated in a selective manner.
cooperative manner. The specificity for CIITA activa- Two promoters direct specific constitutive expression
tion by IFNg is thus dictated by the GAS/E box motif in dendritic cell (promoter I [PI]) and in B lymphocytes
and by theselective interaction of IFNg-activated Stat1 (PIII), whereas another promoter (PIV) mediates IFNg-
and USF-1. This clarifies the missing link in the overall inducible expression in most MHC-II±negative IFNg-
pathway of IFNg activation of MHC-II expression. inducible cells (Muhlethaler-Mottet et al., 1997).
Recently, progress was made in understanding the
Introduction signaling cascade of gene activation in response to
IFNg. Binding of IFNg to its cell-surface receptor acti-
vates the protein tyrosine kinases Jak1 and Jak2. TheMajor histocompatibility complex class II (MHC-II) mole-
latent cytoplasmic transcription factor Stat1 is thencules present exogenous antigenic peptides to CD41
phosphorylated on tyrosines by the Jak kinases andhelper T lymphocytes. A very tight regulation of MHC-
translocates to the nucleus, where it binds to the GASII expression is crucial for the control of the immune
element of IFNg-responsive promoters, leading to generesponse. Constitutive expression is restricted to spe-
activation (Darnell et al., 1994; Schindler and Darnell,cialized antigen-presenting cells, such as dendritic cells
1995; Darnell, 1997). Different studies involved the Jak/and B lymphocytes. In addition, MHC-II expression can
STAT pathway in CIITA inductionby IFNg. Indeed, CIITA,be induced by a number of different stimuli, particularly
like other IFNg-inducible genes, cannot be induced inby interferon-g (IFNg), in a variety of MHC-II±negative
Jak1-deficient cell lines (Chang et al., 1994). Moreover,cells (Glimcher and Kara, 1992; Mach et al., 1996).
CIITA mRNA was not induced by IFNg in bone marrowProgress in understanding the regulation of MHC-II
macrophages derived from Stat12/2 mice (Meraz et al.,genes has come from studies of various regulatory mu-
1996), indicating a role of Stat1 in CIITA induction bytant cell lines affected in MHC-II regulatory factors and
IFNg.of cell lines isolated from patients suffering from heredi-
Analyses of the IFNg-responsive CIITA promoter (PIV)tary MHC-II deficiency (Griscelli et al., 1989; Mach et al.,
and sequence comparison between human and mouse
1994). This disease, also referred to as bare lymphocyte
lead to the identification of several conserved cis-regu-
syndrome, is characterized by a lack of MHC-II expres-
latory elements such as a NF-GMa±binding site, a GAS
sion due to mutations in trans-acting regulatory factors element, an E box, and an IRF-1±binding site (Muhle-
and thus it represents a disease of gene regulation thaler-Mottet et al., 1997). The presence of the GAS
(Mach et al., 1996). Genetic and molecular analyses of element suggests the direct binding of Stat1 to CIITA
these cell lines, corresponding to different complemen- PIV, leading to CIITA expression. The IRF-1±binding site
tation groups, have allowed us to identify and character- can be bound by the members of the interferon regula-
ize three transcription factors essential for the control tory factor (IRF) family of transcription factors, which
of MHC-II regulation: CIITA, RFX-5, and RFX-AP. RFX-5 includes, among others, IRF-1, IRF-2, ISGF3g, and
(Steimle et al., 1995) and RFX-AP (Durand et al., 1997) ICSBP (Boehm et al., 1997).
are components of the RFX complex, which binds to The presence of the canonical E box CACGTG within
the CIITA promoter IV suggests that a member of basic±
helix-loop-helix/leucine zipper (bHLH-zip) class of tran-*To whom correspondence should be addressed (e-mail:mach@
medecine.unige.ch). scription factors might be involved in IFNg-induced
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CIITA expression. This family includes the constitutively
expressed transcription factors TFE3 (Beckmann et al.,
1990), TFEB (Carr and Sharp, 1990), USF-1 (Gregor et
al., 1990), and USF-2 (Sirito et al., 1994), as well as
proteins involved in the Myc network, including Myc-
Max and Mad-Max (Blackwood and Eisenman, 1991;
Ayer et al., 1993).
Here, we report on the mechanisms controlling CIITA
promoter IV activation by IFNg. By mutagenesis and
functional analyses we show that the GAS element, the
E box, and the IRF-1±binding site are all essential for
CIITA PIV activation by IFNg. We demonstrate that Stat1
binds directly to CIITA PIV-GAS element, which com-
pletes the entire cascade of MHC-II induction by IFNg.
We also showthat theubiquitous bHLH-zip transcription
factor USF-1 binds to CIITA PIV-E box. More impor-
tantly, we demonstrate that Stat1 binding to the GAS
site is strongly stabilized by USF-1 and that both factors
bind cooperatively to the GAS/E box motif of CIITA PIV.
We conclude that it is the cooperative interaction be-
tween a ubiquitous factor, USF-1, and an IFNg-activated
protein, Stat1, that controls the specific activation of
CIITA promoter IV by IFNg.
Results
Mutagenesis and Functional Assays Define
Three Essential Cis-Acting Elements
for CIITA Induction by IFNg
Figure 1. Functional Analysis of CIITA Promoter IVSequence analysis of CIITA promoter IV indicated the
presence of four potential cis-acting elements con- (A) The organization of the human wt and mutants CIITA promoter
IV. Sequences and positions of conserved cis-acting elements areserved between human and mouse: a GAS element, an E
indicated. Nucleotides modified for reporter gene assays are shownbox, an IRF-1±binding site, as well as a NF-GMa±binding
below the wt sequence with names of mutant constructs. Oligonu-site (Figure 1A) (Muhlethaler-Mottet et al., 1997). To ana-
cleotides used as probes for EMSA and in competition experiments
lyze the functional relevance of these cis-acting ele- are indicated.
ments, site-directed mutagenesis was performed, fol- (B) Functional analysis of wt and mutagenised CIITA promoter IV.
lowed by functional analyses by promoter-reporter gene Transient transfections of Me67.8 cells with plasmids PIV-308 wt,
Nm, Gm, Em, Im, GmEm, or the promoterless plasmid pGbG(1) andassays, measured by quantitative competitive reverse
the reference plasmid pGbAcbGID. c, RT-PCR signals from CIITAtranscriptase-polymerase chain reaction (RT-PCR) (Sper-
PIV-308/b-globin reporter gene construct; r, signals derived fromisen et al., 1992). A 308 bp fragment of CIITA promoter
reference plasmid. Stimulation index is determined by the ratio be-
PIV (PIV-308 wt), which contains all the elements neces- tween promoter activity after culture with IFNg and after culture in
sary for responsiveness to IFNg, as well as various mu- medium alone, as described earlier (Muhlethaler-Mottet et al., 1997).
tated PIV-308 constructs (Figure 1A) were analyzed for Plotted results are means of three independent experiments with
standard deviations.transcriptional activation in response to IFNg under ex-
perimental conditions described earlier (Muhlethaler-
Mottet et al., 1997) (Figure 1B). Transient transfections
of PIV-308 wt in the IFNg-inducible melanoma cell line the alternative and unlikely explanation that the muta-
tions introduced in this site have created a cryptic bind-Me67.8 showed a very low basal transcriptional activity
of the b-globin reporter construct. Treatment of cells ing site for a positive transcription factor. As a control,
the promoterless construct pGbG(1) showed no tran-with IFNg-induced PIV-308 wt promoter construct activ-
ity, which was referred as 100% of stimulation index scriptional activity upon IFNg induction (8% of wt stimu-
lation index) (neg. in Figure 1B). These results show(Figure 1B). In contrast, mutations in either the GAS
element (Gm), the E box (Em), or the IRF-1±binding site that each of these cis-acting elements are functionally
relevant. Moreover, the strong decrease of promoter(Im) of CIITA promoter IV resulted in an almost complete
abolition of promoter inducibility by IFNg, with stimula- inducibility by IFNg clearly demonstrates that the GAS
element, the E box, and the IRF-1±binding site each playtion index equivalent to 19%, 16%, and 23% of wild-
type (wt) stimulation index, respectively (Figure 1B). The a functionally important role in the induction of CIITA
gene expression by IFNg.same reduction of promoter responsiveness to IFNg was
observed with the double mutant GmEm (17% of wt
stimulation index) (Figure 1B). Conversely, a mutation IRF-1 Is Functionally Essential for CIITA
Promoter IV Inducibility by IFNgin the NF-GMa box showed an increased response to
IFNg (3-fold compared to wt), suggesting a role as a Because we have demonstrated the functional impor-
tance of the IRF-1±binding siteof CIITA PIV and becausenegative control element. However, we cannot exclude
Cooperative Binding between STAT1 and USF-1
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Figure 2. IRF1 Is Essential for CIITA Induction by IFNg
CIITA and IRF-1 mRNA were analyzed by RNase protection assays
in RNAs from embryonic fibroblasts from wt and IRF-12/2 mice,
either unstimulated (O) or stimulated for 6 hr, 12 hr, or 24 hr with
IFNg. A TBP probe was used as internal control. The positions of
the protected fragments and of the undigested probesare indicated. Figure 3. Two Distinct Complexes Can Bind to the NGE Probe
The protected fragment corresponding to IRF-1 mRNA is shorter in EMSA experiments were performed with the NGE probe and nuclear
RNA from IRF-12/2 mice, because the probe covers a part of the extracts from Me67.8 cell line unstimulated (2) or stimulated with
region deleted in the IRF-12/2 mice. IFNg (1). U, upper complex; L, lower complex; F, free probe. (A)
Competition experiments. Competitor DNA (200-fold molar excess,
comp.) added during the binding reactions are indicated. (B) EMSA
IRF-1 was shown to be involved in the induction of sev- performed on mutated NGE probes.
eral IFNg-inducible genes, such as GBP (Briken et al.,
1995), we investigated the role of IRF-1 in the induction
of CIITA by IFNg. RNAs from embryonic fibroblasts (EF) We then analyzed protein-binding activity on mutated
DNA target sequences, using probes containing thederived from wt and from IRF-12/2 mice were compared
for CIITA mRNA expression after stimulation by IFNg. same mutations as the reporter gene constructs Gm or
Em in either the GAS site or the E box, respectively.RNase protection assays revealed that, in contrast to wt
EF, IFNg-induced CIITA mRNA expression was strongly When the GAS element was mutated (NGmE probe),
only the L complex was formed, even with nuclear ex-reduced in IRF-12/2 EF (Figure 2). The same inhibition
of IFNg stimulation was observed, as expected, for GBP tract from IFNg-stimulated cells (Figure 3B). By contrast,
when the E box was mutated (NGEm probe), neither themRNA (data not shown). The results indicate that IRF-1
is an essential factor for CIITA induction by IFNg in EF. L nor the U complex could be formed (Figure 3B). Taken
together, these EMSA data show that complex L con-
sists of an E box±binding protein, which is present inTwo Distinct Protein Complexes Can Be
Formed on the GAS/E Box Region unstimulated cells, and that, following stimulation by
IFNg, a novel U protein complex appears, whose DNATo analyze the protein±DNA complexes that can be
formed within the region containing the three cis-acting binding activity depends on both an intact GAS and E
box. We conclude that this U complex is composed ofelements, NF-GMa/GAS/E box, electrophoretic mobility
shift assay (EMSA) experiments were performed with at least an E box±binding protein and a protein activated
by IFNg, which binds to the GAS site. An obvious candi-a DNA probe covering this region (NGE) and nuclear
extracts from Me67.8 cells, either uninduced or induced date is Stat1, because it has been shown to bind GAS
element following activation by IFNg (Decker et al.,by IFNg (Figures 1A and 3A). With nuclear extracts from
unstimulated cells, a DNA/protein complex (lower [L]) 1991).
was observed (Figure 3A, lane 1). Following stimulation
by IFNg, an additional complex (upper [U]) with a lower Stat1 Controls CIITA Expression by Direct Binding
to the GAS Site of CIITA Promoter IVelectrophoretic mobility was observed (Figure 3A, lane 5).
To analyze the specificity and the DNA-binding sites Because of its known activation following exposure of
cells to IFNg, STAT1 has been thought to play a role inof each of these twocomplexes, we carried out competi-
tion experiments with oligonucleotides specific for ei- the induction of CIITA (Steimle et al., 1994; Lee and
Benveniste, 1996; Muhlethaler-Mottet et al., 1997). Tother the NF-GMa±binding site (N), the GAS site (G), or
the E box (E) (Figure 1A). The results show that the evaluate directly the role of Stat1 in the regulation of
the CIITA gene by IFNg, the Stat1-deficient cell line U3AL complex was disrupted only by competitor oligo E,
whether the nuclear extracts came from unstimulated was compared to the parental fibrosarcoma cell line
2FTGH for it ability to induce CIITA expression uponcells or from IFNg-stimulated cells (Figure 3A, lanes 4
and 8). In contrast, the U complex was disrupted by IFNg stimulation. In contrast to 2FTGH, the U3A cell line
showed neither induction of CIITA mRNA expressioncompetitor oligos covering either the GAS site (G) or the
E box (E) (Figure 3A, lanes 7 and 8). The fact that the nor CIITA promoter IV activation after IFNg stimulation,
as determined by RNase protection assays and promoter-oligo covering the NF-GMa±binding site (N) was not able
to compete for any of these two complexes indicated reporter gene assays, respectively (data not shown).
These results show that Stat1 controls IFNg-inducedthat no protein binds to the NF-GMa±binding site under
these experimental conditions (Figure 3A, lanes 2 and 6). activation of CIITA promoter IV. They are in agreement
Immunity
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Figure 4. Stat1 Is Present in the U Complex
Anti-Stat1 antibodies can supershift the U complex in EMSAs.
EMSAs with the NGE probe and nuclear extracts from IFNg-stimu-
lated Me67.8 (lanes 1±7), from IFNg-stimulated 2FTGH (lane 8), from
IFNg-stimulated U3A (lane 9), or from unstimulated Me67.8 (lanes
10±13), activated rStat1 (10 ng, lanes 11±13), and either no added
antibody (2, lanes 1, 8±11), different amounts of anti-human Stat1 Figure 5. USF-1 Binds to the E Box of CIITA PIV
antibodies (1, lanes 2±6, 13), or nonspecific antibodies (1, lanes 7
(A) Anti-USF-1 antibodies can supershift the U and L complexes inand 12). Monoclonal antibodies dilutions were 1:20 for lanes 2, 7,
EMSA. EMSA were performed with the NGE probe, nuclear extracts12, and 13; 1:200 for lane 3; 1:1000 for lane 4; 1:2000 for lane 5; and
from unstimulated (2) or IFNg-stimulated (1) Me67.8, and either no1:10000 for lane 6. Only the region of the gel containing the upper
antibody (2) or anti-USF-1, anti-Myc, or anti-Max antibodies. Arrow(U) and lower (L) complexes is shown. Arrow indicates supershifted
indicates supershifted complexes; U, upper complex; L, lower com-complexes. In lanes 8, 11, and 12, a small part of the probe is
plex; F, free probe.blocked in the well where the supershifted complex is also blocked.
(B) Analysis of USF-1±binding site. EMSA with rUSF-1 (5 ng) and
either wt NGE, NGmE, or NGEm probes are shown.
with reports showing that CIITA mRNA cannot be induced
by IFNg in bone marrow macrophages from Stat12/2
site is also involved in the formation of the two DNA/mice (Meraz et al., 1996).
protein complexes U and L (Figure 3). The nucleotideTo investigate the role of Stat1 at the level of CIITA
sequence of the E box of CIITA PIV matches the consen-promoter IV and therefore its presence in the IFNg-
sus binding site (CACGTG) of several bHLH-zip DNA-inducible U complex, we analyzed the protein com-
binding proteins, such as c-Myc, Max, or USF-1/2. Toplexes binding to the NGE probe by supershift experi-
determine which of these E box±binding factors inter-ments using monoclonal antibodies specific for Stat1.
acts with CIITA promoter IV, we tested several antibod-While nonspecific monoclonal antibodies (mAbs) could
ies specific for different proteins of the bHLH-zip familynot retard migration of any complex (Figure 4, lanes 7
(Figure 5A). Addition of antibodies directed againstand 12), Stat1-specific antibodies supershifted the U
c-Myc and Max to the binding reactions did not su-complex, even when diluted to 1/2000 (Figure 4, lanes
pershift any of the two complexes. On the other hand,2±6). By contrast, the L complex was not supershifted
polyclonal antibodies specific for USF-1 lead to a su-by anti-Stat1 mAbs (Figure 4, lanes 2±6 and 13). These
pershift of both the U and L complexes (Figure 5A).experiments indicate that Stat1 is present in the IFNg-
This indicates that the E box±binding protein USF-1 isdependent GAS/E box U complex. Finally, EMSA per-
present in both the U and L complexes.formed on the NGE probe with nuclear extract from the
To demonstrate directly the capacity of USF-1 to bindU3A Stat1±deficient cell line did not lead to the formation
to CIITA promoter IV, we performed EMSA with recombi-of the U complex following IFNg induction, whereas this
nant USF-1 protein (rUSF-1). As shown in Figure 5B,U complex was observed with nuclear extract from the
rUSF-1 alone was capable of binding to the NGE probe.2FTGH-induced cell line (Figure 4, lanes 8 and 9).
Moreover, mutations in the E box of NGE probe (NGEm)Addition of recombinant activated Stat1 protein (rStat1)
abolished rUSF-1 binding, whereas mutations in theto nuclear extracts from unstimulated Me67.8 cells al-
GAS element of NGE probe (NGmE) did not (Figure 5B).lowed us to reconstitute the U complex (normally seen
This demonstrates that USF-1, which is present in Uonly after IFNg induction). This reconstituted U complex
and L complexes, can specifically bind to the E box ofwas specifically retarded by anti-Stat1 mAbs (Figure
CIITA promoter IV.4, lanes 11±13). We conclude that Stat1 is the IFNg-
activated component that mediates the formation of the
Close Proximity between Stat1 and USF-1 IsU complex. Together these results clearly demonstrate
Necessary for CIITA Promoter IV Activitythat Stat1 controls IFNg inductionof CIITA gene by direct
To analyze the precise DNA contact points involved inbinding to the GAS element of CIITA promoter IV.
the formation of U and L complexes on the CIITA PIV
GAS/E box motif, methylation interference analysesIdentification of USF-1 as the Essential E Box±Binding
were performed with nuclear extract from IFNg-stimu-Protein on CIITA Promoter IV
lated Me67.8 (data not shown). USF-1 contact pointsFunctional assays have revealed the major importance
of the E box for inducibility by IFNg (Figure 1B), and this span the entire E box and two nucleotides downstream
Cooperative Binding between STAT1 and USF-1
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as the distance between them are limiting features in the
formation of the U complex and therefore in promoter
response to IFNg. A very close proximity between Stat1
and USF-1 is thus necessary for their binding to CIITA
promoter IV and therefore for its activation.
Cooperative Binding between Stat1
and USF-1 to CIITA Promoter IV
USF-1 and Stat1 bind to juxtaposed cis-actingelements,
and their binding is strongly influenced by the distance
and the spatial orientation relative to each other. There-
fore, it was of interest to analyze if the two proteins
USF-1 and Stat1 cooperate in the formation of the IFNg-
induced U complex on CIITA promoter IV. EMSA analy-
ses revealed that, in contrast to rUSF-1, which can bind
alone to the NGE probe, no complex attributable to
rStat1 bound on its own was detected on the NGE probe
(Figure 7A, lanes 3 and 7). Moreover, addition of increas-
ing amount of activated rStat1 to rUSF-1, in excess
of free probe, generated more rStat1/rUSF-1 complex
bound than rUSF-1 bound alone (Figure 7A, lanes 4±6).
Quantification of the amount of probe bound indicated
that the binding was cooperative, because the amount
Figure 6. USF-1 and Stat1 Need Close Proximity to Control CIITA
of probe bound by rStat1/rUSF-1 complex (17%) wasPIV Activity
2.2-fold greater than the sum of the probe bound by
(A) Increasing the distance between the GAS site and E box inhibits
rUSF-1 alone (7.6%) and rStat1 alone (0%) (Figure 7A,CIITA PIV activity. Functional analyses of wt and mutagenised CIITA
lanes 6, 3, and 7, respectively). The cooperative bindingpromoter IV by transient transfections of Me67.8 cells with plasmids
PIV-308 wt, G15E, G110E, or the promoterless plasmid pGbG(1) was similarly observed with nuclearextract from unstim-
and the reference plasmid pGbAcbGID (see Figure 1B). Plotted re- ulated Me67.8 cells and activated rStat1, with a percent-
sults are means of three independent experiments with standard age of probe bound equivalent to39% with rStat1/USF-1
deviations. complex, to 14.7% with USF-1 alone, and 0% with rStat1
(B) Distance between GAS site and E box inhibits Stat1/USF-1 bind-
alone (data not shown). The complexes formed withing. EMSA were performed with nuclear extracts from unstimulated
recombinant proteins have the same migration profiles(2) or IFNg-stimulated (1) Me67.8 and either wt NGE, NG15E, or
NG110E probes. Only the region of the gel containing the upper as those made with nuclear extracts from Me67.8, L and
(U) and the lower (L) complexes is shown. U (Figure 7A, lanes 1, 2, and 6). Therefore, activated
rStat1 either with nuclear extract or with rUSF-1 gave
similar migration profiles and cooperative binding. Thisof it and are similar in positions and intensity for com-
plexes U and L. The binding characteristics of USF-1 indicates that USF-1 is not only capable of binding to
CIITA-E box but also capable of cooperating with Stat1are thus identical when bound alone or together with
Stat1. Stat1 binding involves contact points on the entire to promote its binding to CIITA promoter IV. Also it
suggests that no other protein is necessary for the for-GAS site.
As the GAS site and the E box are juxtaposed on mation of the U complex.
To examine if the cooperative binding of Stat1 andCIITA promoter IV, it was interesting to study if this close
proximity is necessary for USF-1 and Stat1 to bind to USF-1 might have an effect on the stability of the com-
plexes, we performed off-rate measurements to deter-CIITA promoter IV. We inserted 5 or 10 bp between their
respective DNA-binding elements in PIV-308 reporter mine the half-lives of Stat1 alone, USF-1 alone, and the
Stat1/USF-1 complex on the DNA probes. The half-lifeconstructs (G15E and G110E). Me67.8 cells were
transfected with the wt and mutant constructs for func- of Stat1 was determined with activated rStat1 on the
GAS probe (G), because Stat1 did not bind on its owntional analysis. The results showed that insertion of half-
helical turn as well as full-helical turn almost abolished to the NGE probe under these conditions. rStat1 was
very unstable on CIITA-GAS site, with a half-life of lessCIITA PIV reporter construct inducibility by IFNg (13%
and 9% of wt stimulation index, respectively) (Figure than 1 min (Figure 7B, top and bottom). The half-lives
of USF-1 and USF-1/Stat1 were determined with nuclear6A). To analyze the binding capacity of Stat1 and USF-1
on these mutated regions, we carried out EMSA on NGE extract from IFNg-stimulated cells on the NGE probe.
The half-life of USF-1 on the NGE probe was around 7probes bearing the same nucleotides addition as re-
porter constructs (NG15E and NG110E). In contrast min. In contrast, USF-1 and Stat1 together formed a
much more stable complex with a half-life of 20 minto the wt NGE probe, insertion of 5 or 10 nucleotides
between the GAS and E box did not allow the formation (Figure 7B, middle and bottom).
In conclusion, binding of Stat1 on CIITA-GAS siteof Stat1/USF-1 complex (U, Figure 6B). Nevertheless,
USF-1 was still capable of binding alone to these mu- is strongly stabilized by USF-1. Moreover, binding of
USF-1 is also stabilized by Stat1, as the half-life of thetated probes. These results indicate that the spatial ori-
entation of bound factors relative to each other as well Stat1/USF-1 complex is higher than that of USF-1 alone.
Immunity
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Based on the requirement of both the wt E box and GAS
site for the formation of the Stat1/USF-1 U complex and
promoter activity, as well as the cooperative binding of
Stat1 and USF-1 in vitro, we propose that activation of
CIITA promoter IV by IFNg is dependent on the coopera-
tive interaction of Stat1 and USF-1, an interaction that
can only take place once the two factors have been
recruited to their specific DNA-binding site.
Discussion
Both constitutive and inducible MHC-II gene expression,
in different cellular and functional compartments, is quan-
titatively regulated by the same transactivator CIITA and
is therefore dependent on the control of CIITA gene
expression itself. In a previous study (Muhlethaler-Mot-
tet et al., 1997), we have shown that this highly complex
regulation results from the alternative usage of several
distinct promoters of the CIITA gene, which control ei-
ther constitutive expression, in dendritic cells via pro-
moter I, in B lymphocytes via promoter III, or inducible
expression in a variety of other cell types via promoter
IV. Functional analysis of CIITA promoter III and IV have
shown that in both cases the proximal promoter is suffi-
cient to confer tissue-specific expression of a reporter
gene. Sequence conservation between human and mouse
and comparison with known cis-acting elements indi-
cated the presence of several potential cis-regulatory
elements (Muhlethaler-Mottet et al., 1997). The purpose
of this study was to characterize, functionally and bio-
chemically, the cis-acting elements and the trans-acting
factors that participate in the induction of CIITA pro-
moter IV by IFNg and thus control the induction of MHC-
II expression.
By mutagenesis and analysis with reporter gene
assays, we demonstrate the functional importance of
the GAS site, the E box, and the IRF-1±binding site
of CIITA promoter IV, because mutations of each site
separately reduce promoter inducibility by IFNg dramati-
cally. The double mutant (GmEm) does not exhibit more
inhibition compared to the single mutants (Gm or Em),
suggesting that the GAS/E box motif functions as a
single cis-regulatory element. This was observed in dif-
ferent cell types (data not shown). Moreover, functional
analyses revealed that the GAS/E box motif and the
IRF-1±binding site synergise for CIITA PIV activation,
because the sum of the activity resulting from each motifFigure 7. Binding of Stat1 and USF-1 to the NGE Probe Is Strongly
alone (IRF-1 motif with GmEm construct or GAS/E boxCooperative
motif with Im construct) is lower than that observed with(A) EMSA showing the cooperative binding between activated rStat1
and rUSF-1 to NGE probe. EMSA with large excess of NGE probe both motifs together (wt).
and rUSF-1 protein (2 ng) (lanes 3±6), either alone (lane 3), or with The functionally essential role of the IRF-1±binding
increasing amount of rStat1 (lane 4, 5 ng; lane 5, 20 ng; and lane 6, site of CIITA PIV, as well as the drastic inhibition of
50 ng), or rStat1 alone (lane 7, 50 ng). EMSA with nuclear extract
CIITA mRNA induction by IFNg in IRF-1±deficient cells,from Me67.8 (lane 1, 2IFNg; lane 2, 1IFNg).
indicate a functional role of IRF-1 in CIITA promoter IV(B) Stat1 is strongly stabilized by USF-1 on the CIITA PIV GAS site.
Top: activated rStat1 (10 ng) was incubated with the G probe to
allow complexes formation and then supplemented with a 500-fold
molar excess of unlabeled G or N competitor oligonucleotides. After
0, 1, 2, 3, or 4.5 min, a sample was directly loaded on a 5% polyacryl- phoresis. Bottom: off-rates measurements of Stat1 and USF-1 either
amide gel. Middle: the Stat1/USF-1 complex is more stable than alone or as a Stat1/USF-1 complex. Gels were quantified by Phos-
USF-1 alone on NGE probe. Nuclear extract from Me67.8 stimulated phorImager analysis. The percentage of complexes bound to DNA
with IFNg was first incubated with NGE probe to allow complexes after adjunction of the competitor is plotted as a function of time.
formation, supplementedwith a 500-foldexcess of unlabeled NGmE U, upper complex; L, lower complex; S, Stat1 competed with G
competitor oligonucleotide (competing U and L complexes), and oligo. For Stat1, 100% of complex bound corresponds to 0 min with
then continued for 0, 2, 5, 10, 15, 30, and 60 min before gel electro- the N oligonucleotide as competitor.
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activation, very likely through binding to CIITA PIV. The promoter IV. Indeed, USF-1 without Stat1 is not able to
observed requirement for IRF-1 is in agreement with a activate CIITA PIV, as shown by reporter gene assay
previous report showing a reduced induction of CIITA with a mutated GAS site and by the use of Stat1 mutant
mRNA in IRF-12/2 mice (Hobart et al., 1997). IRF-1 is cells.
involved in the regulation of other IFNg-inducible genes, Modification of the spatial orientation (15) or distance
such as GBP and iNOS (Kamijo et al., 1994; Briken et (110) between GAS and E box abolishes cooperative
al., 1995). Because the synthesis of IRF-1 is itself rapidly binding of Stat1 and USF-1, as well as inducibility of
induced by IFNg, CIITA dependence on IRF-1 explains promoter IV to IFNg. Therefore, cooperative binding of
the slight delay in the kinetics of IFNg induction and USF-1 and Stat1 and subsequent promoter activation
the partial dependence on de novo protein synthesis require not only the integrity of the GAS site and of the
observed similarly in the case of GBP and CIITA induc- E box sequences but also their relative position and
tion by IFNg (Steimle et al., 1994). distance. The simultaneous addition of activated rStat1
Different studies implicated Stat1 in the control of and USF-1 generates an increased amount of rStat1/
CIITA expression without addressing its mode of action. USF-1 complex, compared to the amount of rStat1 and
First, CIITA mRNA was not expressed in IFNg-stimulated USF-1 bound alone, indicative of highly cooperative in-
bone marrow macrophages from Stat12/2 mice (Meraz teractions. Indeed, cooperativity is defined by an in-
et al., 1996). Second,Stat1 antisense experimentsshowed crease in the number of promoter-bound complexes
a reduction of Stat1 protein synthesis leading to a reduc- when both factors are present in comparison to the
tion in CIITA induction by IFNg (Lee and Benveniste, number observed with either factor alone.
1996). Here, we have analyzed the role of Stat1 in the The strong cooperativity between Stat1 and USF-1
induction of CIITA by IFNg directly at the level of CIITA for binding to CIITA PIV was also demonstrated by an
promoter IV. We demonstrate with reporter gene assays analysis of the stability of the complexes bound to DNA.
that CIITA PIV is unresponsive to IFNg in the Stat1- Off-rate experiments showed that, although Stat1 has
deficient cell line U3A (data not shown). Moreover, we a dramatically short half-life on the CIITA-GAS site, the
show, by EMSA and with competitor oligonucleotides, half-life of the Stat1/USF-1 complex is considerably ex-
antibodies directed against Stat1 and activated rStat1 tended. Binding of Stat1 to CIITA PIV is therefore
that Stat1 binds directly to the CIITA PIV-GAS site. strongly stabilized by the presence of USF-1. The bind-
The essential role of the canonical E box within the ing of USF-1 is also stabilized by the presence of Stat1,
CIITA promoter IV, as demonstrated by mutagenesis because the half-life of the Stat1/USF-1 complex is three
experiments, strongly suggested that a member of times that of USF-1 alone. This strong cooperativity be-
bHLH-zip class of transcription factor may be involved tween Stat1 and USF-1 is in agreement with the results
in IFNg-induced CIITA expression. Among the multiple obtained by functional assays and EMSA, showing that
members of this family of transcription factors, the ubiq- in the absence of USF-1 binding, Stat1 alone is neither
uitous factor USF-1 has been shown here to be a key capable to bind nor to activate CIITA promoter IV. It also
player in the induction of CIITA expression. Indeed, explains why the GAS/E box motif functions as a single
EMSA with competitor oligonucleotides, USF-1±specific cis-regulatory element.
antibody, and recombinant USF-1 protein demonstrate The principle of cooperative binding of two or more
the binding of USF-1 to the E box of CIITA PIV. USF-1/ transcription factors on DNA implies that such proteins
USF-2 can bind to DNA as homo- or heterodimers, and do not spontaneously interact until they are recruited
the ratio can vary depending on the cell type. EMSA to their respective DNA target, which allows them to
with a-USF-1 antibody show that all the U and L com- retain their full potential for binding to different promot-
plexes are supershifted, indicating that no USF-2 homo-
ers and for association with different protein partners,
dimers are bound to the NGE probe. In addition, experi-
as is known to be the case for Stat1 and USF-1. Initial
ments with USF-1 recombinant proteindemonstrate that
binding of individual factors to their DNA target, even
rUSF-1 homodimers are able to bind to the NGE probe
at low affinity, is thus a prerequisite for subsequenton their own, without USF-2, and tocooperate with Stat1
interactions between the two protein partners, whichto form the Stat1/USF-1 U complex.
results in the stabilization of the multiprotein complexUSF is expressed ubiquitously and contributes to the
on DNA and eventually in gene activation. In an alterna-regulation of multiple genes, some of which are ex-
tive but not exclusive model, binding of one factor mightpressed in a tissue-specific or inducible manner. The
produce a structural modification in an adjacent DNAhuman growth hormone gene (Peritz et al., 1988), the
site that facilitates binding of a second factor. Such animmunoglobulin l2 chain gene (Chang et al., 1992), the
effect is considered unlikely on such a short DNA probehuman b-globin control region (Caterina et al., 1994),
and without any chromatin structure.and the p53 gene (Reisman and Rotter, 1993) are all
The case of CIITA promoter IV is, to our knowledge,regulated to some extent by USF. USF was also impli-
the first example of cooperative interaction betweencated in the TGF-b1±responsive element in the human
Stat1 and an ubiquitous transcription factor, such asplasminogen activator inhibitor gene (Riccio et al., 1992).
USF-1, in the selective activation of a given promoter.Because USF is expressed ubiquitously, the tissue-spe-
The same applies to USF-1. Stat1 can interact with CBP/cific expression of the target gene must therefore be
p300, a transcriptional coactivator known to potentiatespecified by the contribution of other transcription fac-
the activity of different transcription factors (Zhang ettors. In the case of CIITA gene activation, it is the activa-
al., 1996). Stat1 has also been shown to synergise withtion of Stat1 by IFNg that confers to USF-1 its specific
activity, as the result of their cooperative binding to other transcription factors like Sp1 (Look et al., 1995)
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Activation of CIITA promoter IV by IFNg represents an
additional example where specificity in gene activation
depends on composite DNA elements. Specificity relies
on both DNA±protein and protein±protein interactions,
in this case between the IFNg induced Stat1 and the
ubiquitous bHLH-zip USF-1. We had observed a similar
phenomenon in the case of MHC class II promoters,
where cooperative interactions between the RFX com-
plex and other factors (X2bp and NF-Y) were shown to
be essential for stable binding of these complexes and
activation of transcription (Reith et al., 1994a, 1994b;
Mach et al., 1996). Combinatorial interactions between
tissue-specific, developmentally restricted, and ubiqui-
tous transcription factors is an efficient way to achieve
selective activation of multiple individual genes, as the
result of specific combination of a restricted set of cis-
acting elements, each capable of binding a limited num-
ber of transcription factors.
Figure 8. The Entire Cascade of the Induction of MHC-II Genes
Expression by IFNg Experimental Procedures
Cellsor NFkB (Ohmori et al., 1997) to increase promoter activ-
The cell lines Me67.8 (melanoma cell line, provided by S. Carrell)ity, but in these cases, there was no evidence of cooper-
and THP1 (monocytic cell line) were grown in RPMI-1640 medium.ativity in the binding of the two factors.
The cell lines 2FTGH (fibrosarcoma cell line) and U3A (Stat1 mutant
The mechanism of CIITA induction by IFNg can be from 2FTGH), both a gift from I. Kerr, were grown in Dulbecco's
distinguished from that of other IFNg-inducible genes modified Eagle's medium. Mediums were supplemented with 10%
by the strict requirement for USF-1, as an essential part- fetal calf serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2
mM L-glutamine and incubated at 378C in 5% CO2.ner for Stat1 binding and activity. This unique and func-
tionally essential cooperative interaction between Stat1
Reporter Gene Assaysand USF-1 for the activation of CIITA expression and
Reporter gene expression was measured by quantitative RT-PCRthus for the induction of MHC class II molecules points
as previously described (Sperisen et al., 1992). Transfections, RNAto a highly selective novel target for potential immuno-
preparations, and RT-PCR analyses were performed as previouslymodulators. Indeed, it should be possible to affect this
described (Muhlethaler-Mottet et al., 1997). Plasmid PIV-308 con-
cooperative interaction selectively, ideally without com- tains the 2308 to 175 fragment of the 59 flanking region of CIITA
promising the role of each of the two factors in the promoter PIV subcloned upstream of the rabbit b-globin gene of
activation of other promoters, or to selectively block the plasmid pGbG(1). Mutagenesis was performed by introduction of
binding of the Stat1/USF-1 complex (Choo et al., 1994). restriction endonuclease sites by PCR, generating four to five nucle-
otide modifications per mutated binding site. The input ratio be-The physiological implications of a selective experimen-
tween CIITA constructs and the reference plasmid was 9:1. RT-PCRtal inhibition of inducible expression of MHC class II
products were denatured and separated by electrophoresis on 6%genes, via the inducible promoter of CIITA, without com-
polyacrylamide 8 M urea gel. mRNA-derived signals were quantifiedpromising MHC class II expression on professional anti- by PhosphorImager. Promoter activity was determined by normaliz-
gen-presenting cells, might be of great biological and ing the mRNA signal derived from CIITA construct to that obtained
pharmacological interest. with the reference plasmid.
The identification of the key players and the mecha-
nisms of their involvement, including the demonstration RNase Protection Assays
that Stat1 controls CIITA induction by direct binding to RNAs from EF from wt and IRF-12/2 mice were a gift from M. Matsu-
moto and T. Taniguchi (Kimura et al., 1994). For the IRF-1 probe, athe functionally essential GAS element of CIITA pro-
fragment was constructed that covers nucleotides 797 (NdeI) tomoter IV cooperatively with USF-1, allows us to fill the
1061 (XhoI), protecting 264 bp of IRF1 mRNA. In IRF-12/2 EF, thislast missing gap in the entire cascade of MHC-II genes
probe covers nucleotides 874 to 1061 (XhoI), protecting 187 bp ofinduction by IFNg (Figure 8). This cascade begins with
IRF-12/2 mRNA. CIITA and TBP probes were described elsewhere
the binding of IFNg to its receptor, leading to dimeriza- (Otten et al., 1998). RNase protection assays with 10 mg of RNA per
tion of the receptor, activation of Janus kinase 1 and 2 reaction were carried out as previously described (Steimle et al.,
by tyrosine phosphorylation, and tyrosine phosphoryla- 1993).
tion of receptors cytoplasmic domains allowing interac-
tion with Stat1. Stat1 is then activated by tyrosine phos- Oligonucleotides
phorylation, dimerizes, and translocates to the nucleus. NGE: 59-ggCCAGGCAGTTGGGATGCCACTTCTGATAAAGCACGTG
GTGGCCACAG-39; N: 59-ggCAGTTGGGATGCCACTTCT-39; G: 59-ggThere it binds to the GAS element of CIITA promoter IV,
CCACTTCTGATAAAGCAC-39; E: 59-gggAAAGCACGTGGTGGCC-39;where it is stabilized by its cooperative interaction with
NGmE: 59-ggCCAGGCAGTTGGGATGCCACGAATTCTAAAGCACGUSF-1, and activates the transcription of CIITA mRNA.
TGGTGGCCACAG-39; NGEm: 59-ggCCAGGCAGTTGGGATGCCACCIITA then operates as the essential mediator of MHC-
TTCTGATAAAGGAATTCGTGGCCACAG-39; NG15E: 59-ggCCAGGC
II gene induction (Steimle et al., 1993; Steimle et al., AGTTGGGATGCCACTTCTGATAAACTCGAGCACGTGGTGGCCAC
1994). It activates MHC-II gene expression as a coactiva- AG- 39; and NG110E: 59-ggCCAGGCAGTTGGGATGCCACTTCTGA
tor interacting with the promoter-bound transcription TAAACTCGAGCTAGGCACGTGGTGGC CACAG-39. Mutations are
underlined.factors (Figure 8).
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EMSA and Methylation Interference Analysis control region 59 HS 2 are involved in enhancer activity and position-
independent, transgene expression. Nucleic Acids Res. 22, 1006±Cells were stimulated or not by IFNg (500 U/ml) for 30 min prior to
1011.nuclear extract preparation as described by Harroch et al. (1994).
The oligonucleotides were annealed with their complementary se- Chang, L.A., Smith, T., Pognonec, P., Roeder, R.G., and Murialdo,
quences, end-labeled by [g-32P]ATP with T4 PNK, and gel-purified. H. (1992). Identification of USF as the ubiquitous murine factor that
For binding reaction with the NGE probes, 6 mg of nuclear extract binds to and stimulates transcription from the immunoglobulin
proteins was mixed with 2 3 104 cpm DNA probe, 1.25 mg poly lambda 2-chain promoter. Nucleic Acids Res. 20, 287±293.
(dI)(dC) (Pharmacia), 0.5 mg Escherichia coli single-stranded DNA, Chang, C.H., Fontes, J.D., Peterlin, M., and Flavell, R.A. (1994). Class
with or without competitor, in a final volume of 20 ml containing 20 II transactivator (CIITA) is sufficient for the inducible expression of
mM Tris-HCl (pH 7.9), 50 mM NaCl, 1 mM EDTA, 5% (v/v) glycerol, major histocompatibility complex class II genes. J. Exp. Med. 180,
5 mM dithiothreitol, 1 mM spermidine, and 100 mg bovine serum 1367±1374.
albumin. Binding reactions with the G probe were performed with
Choo, Y., Sanchez Garcia, I., and Klug, A. (1994). In vivo repressionthe following modifications: no poly(dI)(dC), no E. coli single-
by a site-specific DNA-binding protein designed against an onco-
stranded DNA, in a final volume of 20 ml containing 20 mM Tris-HCl
genic sequence. Nature 372, 642±645.
(pH 7.9), 40 mM KCl, 2.5 mM MgCl2, 1 mM EDTA, 5% (v/v) glycerol,
Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277,5 mM dithiothreitol, 1 mM spermidine, and 100 mg bovine serum
1630±1635.albumin. Purified recombinant activated Stat1 (a gift from R.
Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT path-Schreiber) (Greenlund et al., 1995) and purified recombinant USF-1
ways and transcriptional activation in response to IFNs and other(a gift from P. Pognonec) (Roy et al., 1991) were used in the same
extracellular signaling proteins. Science 264, 1415±1421.conditions. After addition of the labeled probe, the mixture was
incubated 30 min at 208C. For supershift experiments, antibodies Decker, T., Lew, D.J., Mirkovitch, J., and Darnell, J.E. (1991). Cyto-
were added (as described in figure legends) and left 20 min at 48C plasmic activation of GAF, an IFNgamma-regulated DNA-binding
before gel electrophoresis in 5% acrylamide/bisacrylamide (29:1) factor. EMBO J 10, 927±932.
gels with 0.25 3 TBE for 3 hr at 200 V at 48C with recirculating buffer. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach,
Gels were dried and subjected to autoradiography. Quantifications B., and Reith, W. (1997). RFXAP, a novel subunit of the RFX DNA
were carried out by PhosphorImager. binding complex is mutated in MHC class II deficiency. EMBO J.
Antibodies against Stat1 (SATO-20.1, a gift from R. Schreiber) and 16, 1045±1055.
negative control (a gift from S. Izui) are mAbs from hybridoma culture
Glimcher, L.H., and Kara, C.J. (1992). Sequences and factors: a
supernatants. Antibodies against USF-1 (provided by R.G. Roeder guide to MHC class-II transcription. Annu. Rev. Immunol. 10, 13±49.
and P. Pognonec) (Pognonec and Roeder, 1991), Myc and Max (both
Greenlund, A.C., Morales, M.O., Viviano, B.L., Yan, H., Krolewski,a gift from B. Amati) (Littlewood et al., 1992) are polyclonal antisera.
J., and Schreiber, R.D. (1995). Stat recruitment by tyrosine-phos-Methylation interference analysis were performed as previously
phorylated cytokine receptors: an ordered reversible affinity-drivendescribed (Kobr et al., 1990), except that binding reactions were
process. Immunity 2, 677±687.set up as described above.
Gregor, P.D., Sawadago, M., and Roeder, R.G. (1990). The adenovi-
rus major late transcription factor USF is a member of the helix-Acknowledgments
loop-helix group of regulatory proteins and binds to DNA as a dimer.
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